# Relaxed multi-module round-2 P1-C audit

> Date: 2026-06-21
> Scope: P1 concrete-module boundary follow-up focused on `ASD-0033`, with a source-access retry on `ASD-0035`.
> Rule: only high-confidence changes supported by first-hand paper evidence are written back to the master list and Notes.

## 本轮结论

本轮关闭 1 条 P1 边界项，并确认 1 条仍需保留在 source-limited 队列中：

| ID | Title short | Sources checked | Decision | Note action |
|---|---|---|---|---|
| `ASD-0033` | OmniCellAgent | PMC HTML full text `PMC12324537` | accepted `scientific_object_modules=06`; keep `primary_module_for_filing=06`; do not add `07` | revised `Notes/06_Life_Sciences/Huang_2025_OmniCellAgent.md` |
| `ASD-0035` | SciAgents | DOI redirect for `10.1002/adma.202413523`; Wiley landing retry | still open; no module expansion landed | no note rewrite this round |

## Evidence summary

### `ASD-0033` OmniCellAgent

- Agent evidence: the PMC full text shows an Orchestrator that builds Task Log / Task Plan / Progress Log and dispatches Omic Data Agent, PubMed Paper Search Agent, Google Search Agent, and Scientist Expert Agent across a multi-step workflow.
- `06` evidence: the concrete scientific objects are single-cell / omics datasets, disease-context cell states, differentially expressed genes, enriched pathways, and disease-association outputs. The methods section explicitly centers scRNA-seq retrieval, DEG analysis, Enrichr enrichment, GO / KEGG / Reactome / MSigDB / OMIM / DisGeNET integration, and visual summaries.
- Why `07` is not accepted: the paper uses precision-medicine, patient, clinician, treatment, and therapy language in the abstract and introduction, but the reported workflow and evaluation do not advance to patient-level clinical decision support, therapeutic ranking, wet-lab therapeutic validation, or clinical-outcome assessment. The results section mainly evaluates biomedical QA with BERTScore / BioASQ and demonstrates disease-mechanism / omics analysis.
- Accepted action: close the `06/07` boundary item as `06` only under the relaxed rule, and revise the note to remove the old “needs another review” wording.

### `ASD-0035` SciAgents

- Source-access retry used the canonical DOI in the master list: `10.1002/adma.202413523`.
- DOI resolution successfully redirects to Wiley (`advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202413523`), which confirms the canonical publisher landing path.
- The Wiley landing page remained blocked by a Cloudflare challenge in this run, so no new first-hand abstract / full-text evidence was available beyond existing metadata-level leads.
- Accepted action: keep `ASD-0035` open in the P1 queue; do not add biology coverage and do not rewrite the note from stale metadata alone.

## Count update

Post-P1-C partial overlay counts are unchanged because `ASD-0033` lands as a single-module `06` record and `ASD-0035` remains open:

| Scientific object module | Expanded assignment count |
|---|---:|
| `01` | 55 |
| `02` | 37 |
| `03` | 79 |
| `04` | 108 |
| `05` | 35 |
| `06` | 74 |
| `07` | 68 |
| `08` | 3 |
| `09` | 36 |
| `10` | 24 |
| `11` | 34 |

| Metric | Count |
|---|---:|
| Record-level confirmed included-and-classified count | 451 |
| Expanded module assignment count | 553 |
| Independent `01.04` general-method bucket count | 19 |

## Remaining uncertainty

- `ASD-0035` remains a live `04`-plus-possible-biology boundary case because the canonical Wiley landing page is still access-limited by Cloudflare in this run.
- No taxonomy-level instability was found in `ASD-0033`; the boundary question is resolved by first-hand full-text evidence and the medical framing is not enough by itself to trigger `07`.
